Ramsay Health Care has released its Preliminary Final Report for the full year ended 30 June 2026, marking the formal disclosure of annual results to the ASX. The announcement confirms that the company’s Appendix 4E, full-year results, and FY26 Investor Presentation are now available, with a live webcast hosted by Group CEO Natalie Davis and Group Executive Finance Anthony Neilson commencing at 10:00am AEDT on 27 August 2026.
As one of Australasia’s largest private healthcare operators, Ramsay’s annual results carry significant weight for investors tracking the health services sector. The preliminary report signals the formal transition from operational reporting to detailed financial disclosure, giving shareholders and analysts the opportunity to assess performance across the company’s three key geographic divisions: Australia, the United Kingdom, and Europe. The results period encompasses a full year of trading across a diversified portfolio spanning private hospitals, day surgeries, mental health facilities, and diagnostic imaging centers.
The webcast represents a critical opportunity for investors to hear directly from management on financial performance, operational metrics, capital allocation decisions, and guidance for the coming year. The format, which includes a live question and answer session, allows participants to clarify specific line items or strategic directions immediately rather than waiting for investor calls or written responses. A recording and transcript will be published later in the day for those unable to attend the live event, ensuring broad access to management commentary.
For equity investors, several areas warrant close attention in the detailed results. These include like-for-like revenue trends and patient volume trends across each division, reflecting demand for private healthcare services. Operating leverage and cost management will indicate how effectively management navigated wage pressures and inflation during the reporting period. The balance sheet position and debt levels are particularly relevant given the capital-intensive nature of healthcare operations and the company’s historical use of acquisitions to drive growth. Free cash flow generation and capital expenditure plans provide insight into the company’s capacity to fund growth, service debt, and return capital to shareholders.
Another key consideration involves Ramsay’s European operations, which experienced significant corporate activity during the reporting period. The company initiated a demerger of its Ramsay Santé French operations, a material event that may have implications for earnings, cash flow, and strategic positioning that warrant careful review in the full results and management commentary. Investors will likely seek clarity on the timing and expected outcomes of this separation.
The availability of the full Appendix 4E, investor presentation, and management webcast provides the complete information set needed for a thorough assessment of the company’s FY26 performance and forward trajectory. Investors should review all three components in sequence, using the presentation as a high-level overview before diving into the detailed financial statements and notes in the Appendix 4E. The question and answer session offers a final opportunity to test management assumptions and expectations before updating investment theses. This announcement is price sensitive and has been flagged as material by the ASX.
View the full ASX announcement (PDF)
About Ramsay Health Care Limited (ASX: RHC)
Ramsay Health Care Limited is an Australian multinational healthcare provider that operates approximately 500 facilities including hospitals, day surgery centers, clinics, and pharmacy services. The company specializes in surgery, rehabilitation, and psychiatric care across Australia, the United Kingdom, France, Scandinavia, Germany, and parts of Asia. It is one of the largest private hospital operators globally.
If you would like to discuss this announcement or how it might affect your portfolio, request a callback or call us on 1300 889 603.
